HBLVX
Price
$14.85
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Net Assets
11.84B
JNBCX
Price
$10.10
Change
+$0.02 (+0.20%)
Updated
Jun 27 closing price
Net Assets
8.29B
Interact to see
Advertisement

HBLVX vs JNBCX

Header iconHBLVX vs JNBCX Comparison
Open Charts HBLVX vs JNBCXBanner chart's image
Hartford Balanced Income R6
Price$14.85
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.84B
JPMorgan Income Builder C
Price$10.10
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets8.29B
HBLVX vs JNBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HBLVX vs. JNBCX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLVX is a Buy and JNBCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLVX has more cash in the bank: 11.8B vs. JNBCX (8.29B). JNBCX pays higher dividends than HBLVX: JNBCX (5.22) vs HBLVX (3.63). HBLVX was incepted earlier than JNBCX: HBLVX (11 years) vs JNBCX (18 years). JNBCX (1.57) is less costly to investors than HBLVX (0.56). JNBCX is a more actively managed with annual turnover of: 107.00 vs. HBLVX (61.00). HBLVX has a lower initial minimum investment than JNBCX: HBLVX (0) vs JNBCX (1000). JNBCX annual gain was more profitable for investors over the last year : 9.73 vs. HBLVX (6.03). JNBCX return over 5 years is better than : 24.19 vs. HBLVX (20.72).
HBLVXJNBCXHBLVX / JNBCX
Total Expense Ratio0.561.2545%
Annual Report Gross Expense Ratio0.561.5736%
Fund Existence11 years18 years-
Gain YTD5.1286.40380%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B8.29B142%
Annual Yield % from dividends3.635.2270%
Returns for 1 year6.039.7362%
Returns for 3 years16.9822.8474%
Returns for 5 years20.7224.1986%
Returns for 10 years44.4643.31103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EUGCX25.950.24
+0.93%
Morgan Stanley Europe Opportunity L
RGAEX80.730.66
+0.82%
American Funds Growth Fund of Amer R4
CDHRX35.060.26
+0.75%
Calvert International Responsible Idx R6
FCVCX15.770.06
+0.38%
Fidelity Advisor Small Cap Value C
ASICX25.320.01
+0.04%
Invesco EQV Asia Pacific Equity C